The effect of a lymphotoxic factor in the sera of patients with multiple sclerosis and acute leukemia on the metabolism of normal and leukemic lymphocytes.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D046508:Culture Techniques; D003864:Depression, Chemical; D005260:Female; D006801:Humans; D007223:Infant; D037102:Lectins / Q000037:antagonists & inhibitors; D007938:Leukemia / Q000097:blood*; D007945:Leukemia, Lymphoid / Q000097:blood*; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000097:blood*; D011241:Prednisone / Q000494:pharmacology; D012313:RNA / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D014118:Toxins, Biological / Q000494:pharmacology*; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D037102:Lectins; D012334:RNA, Neoplasm; D014118:Toxins, Biological; D014316:Tritium; D012313:RNA; D011241:Prednisone; D014529:Uridine